US2023111666A1PendingUtilityA1
Therapeutic delivery vesicles
Est. expiryApr 12, 2033(~6.7 yrs left)· nominal 20-yr term from priority
Inventors:Samir El AndaloussiOscar WiklanderJoel NordinEdvard SmithKarl-Henrik GrinnemoOscar Simonson
A61K 38/177A61P 17/06A61P 21/00A61P 25/00A61K 38/00A61K 47/6911A61K 9/00A61P 11/00F01C 1/3442A61P 13/12F01C 21/102A61P 31/00A61K 47/62A61P 35/00A61P 37/02A61P 29/00C07K 14/70596C07K 2319/00A61P 19/02A61P 1/14A61P 15/00A61P 3/10A61P 1/04C07K 14/705A61P 1/16C07K 14/70578A61P 17/00A61P 9/00A61P 9/10
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention pertains to inter alia methods for purifying extracellular vesicles including exposing a sample comprising at least one extracellular vesicle to ultrafiltration; and exposing the sample following the ultrafiltration in step (i) to size exclusion liquid chromatography.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for purifying extracellular vesicles comprising:
(i) exposing a sample comprising at least one extracellular vesicle to ultrafiltration; and (ii) exposing the sample following the ultrafiltration in step (i) to size exclusion liquid chromatography.
2 . A method of claim 1 , wherein at least one filter is used during ultrafiltration.
3 . A method of claim 2 , wherein the at least one filter comprises a molecular weight cut-off of 100 kDa.
4 . A method of claim 2 , wherein the at least one filter comprises a molecular weight cut-off of 200 kDa.
5 . A method of claim 2 , wherein the at least one filter comprises a molecular weight cut-off of 500 kDa.
6 . A method of claim 1 , wherein at least two different filters are used during ultrafiltration and wherein the at least two different filters have the same molecular weight cut-off.
7 . A method of claim 1 , wherein at least two different filters are used during ultrafiltration and wherein the at least two different filters have a different molecular weight cut-off.
8 . A method of claim 1 , further comprising prior to step (i) exposing the sample to stress-inducing conditions.
9 . A method of claim 8 , wherein the stress-inducing conditions are oxygen deprivation, serum starvation, or a combination thereof.
10 . A method of claim 1 , further comprising prior to step (i) exposing the sample to autophagy-inhibiting substances.
11 . A method of claim 1 , wherein the extracellular vesicles purified using ultrafiltration followed by size exclusion liquid chromatography comprise less protein contamination than extracellular vesicles purified using ultrafiltration alone.
12 . A method of claim 1 , wherein the extracellular vesicles purified using ultrafiltration followed by size exclusion liquid chromatography comprise less vesicle distortion and improved vesicle integrity than extracellular vesicles purified using ultrafiltration alone.
13 . A method for purifying extracellular vesicles, comprising:
(i) introducing at least one polynucleotide construct encoding at least one polypeptide into a cell capable of producing extracellular vesicles; (ii) collecting the extracellular vesicles produced by the cell of step (i); and (iii) purifying the extracellular vesicles collected in step (ii) using ultrafiltration followed by size exclusion liquid chromatography.
14 . A method of claim 13 , wherein at least one filter is used during ultrafiltration.
15 . A method of claim 14 , wherein the at least one filter comprises a molecular weight cut-off of 100 kDa.
16 . A method of claim 14 , wherein the at least one filter comprises a molecular weight cut-off of 200 kDa.
17 . A method of claim 14 , wherein the at least one filter comprises a molecular weight cut-off of 500 kDa.
18 . A method of claim 13 , wherein at least two different filters are used during ultrafiltration and wherein the at least two different filters have the same molecular weight cut-off.
19 . A method of claim 13 , wherein at least two different filters are used during ultrafiltration and wherein the at least two different filters have a different molecular weight cut-off.
20 . A method of claim 13 , further comprising prior to step (ii) exposing the cell to stress-inducing conditions.
21 . A method of claim 20 , wherein the stress-inducing conditions are oxygen deprivation, serum starvation, or a combination thereof.
22 . A method of claim 13 , further comprising prior to step (ii) exposing the cell to autophagy-inhibiting substances.
23 . A method of claim 13 , wherein the extracellular vesicles purified using ultrafiltration followed by size exclusion liquid chromatography comprise less protein contamination than extracellular vesicles purified using ultrafiltration alone.
24 . A method of claim 13 , wherein the extracellular vesicles purified using ultrafiltration followed by size exclusion liquid chromatography comprise less vesicle distortion and improved vesicle integrity than extracellular vesicles purified using ultrafiltration alone.Join the waitlist — get patent alerts
Track US2023111666A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.